- Page 1
-
FDA Recalls Dialysis Drugs Granuflo And Naturalyte Milwaukee pharmaceutical lawyers warn about the FDA Recall of Fresenius Medical Care's dialysis drugs Granuflo and Naturalyte and their side effects. -
Avandia Finalizes Heart Attack Risk Warning Label The FDA recently ordered drug giant GlaxoSmithKline to change the label and use of their diabetes drug, Avandia. -
Avandia Maker to Pay Over $3.4 Billion in Damages GlaxoSmithKline are currently expecting to have to pay $3.4 billion to settle class action lawsuits. -
Could Metal Hip Implants Have a Negative Impact? Re-operation and re-replacement of defective hips may not be the only hip replacement issue that implant patients are facing. -
Recall Of Avandia, Other Prescription Drugs, A Danger In WI Should the FDA be doing more to prevent potentially dangerous drugs from entering the market? Many believe that the answer is yes. -
Johnson & Johnson Faces Recalls, Citations & Plant Closures Johnson & Johnson is in more trouble over quality control issues. The pharmaceutical giant has faced multiple recalls due to possible dangerous contamination. -
Wisconsin Affected by Massive Infusion Pump Recalls The FDA has recently announced a rash of recalls over medical devices. The latest, a serious class 1 recall, involves the Sigma Spectrum Infusion Pump. -
FDA Takes a Closer Look at Defibrillators Though defibrillators can and do save thousands of lives a year, the FDA is concerned that the steady stream of recalls indicates a serious problem. -
Diet Drug Meridia Found to Increase Heart Attack Risk Many are calling for the FDA to take a prescription diet drug off of the market immediately. -
Despite Heart Risks Avandia Will Remain on the Market Avandia, a once popular prescription diabetes drug, will stay on the market for now. -
FDA Adds Liver Injury Warnings to Drugs Alli and Xenical After a study into claims that the weight loss drugs Alli and Xenical may cause severe liver injury the FDA has added new warnings to the labels for the drugs. -
Avandia Under Scrutiny After Link to Heart Failure, Death Researchers are asking the FDA to delay or call off clinical trials of the drug rosiglitazone, or Avandia.